‘Grand Theft Auto VI’ Rebuilds Its Open World Around Consequences, Reactive NPCs, and Shifting Bodies
Rockstar Games has detailed some of Grand Theft Auto VI's core gameplay systems, laying out a version of its open world that reacts to players more closely than any entry before it.…
Speaking with Dazed, senior Rockstar developers confirmed a grounded, …
The foundational shift is reactivity.
Where past games let players move through the map largely unchecked, G…
Rupert Grint to Reprise Ron Weasley in 'Harry Potter and the Cursed Child' on Broadway
SummaryRupert Grint will step back into the role of Ron Weasley after 15 years for a limited Broadway runThe actor will star in Harry Potter and the Cursed Child at the Lyric Theatre from February 2 to May 30 2027Presale tickets for the 17-week engagement begin on September 1 following online registrationBroadway’s production of Harry Potter and the Cursed Child is set to welcome Rupert Grint back to his iconic role as Ron Weasley.…
The actor will reprise the character for the first time in 15 years fo…
Grint, who portrayed the character across all eight original feature f…
His 17-week engagement runs from February 2 to May 30, 2027, following…
Chopova Lowena Doubles Down on Experience, Service with ‘Clubhouse’ Retail Concept
After years of welcoming VICs into their studio, Emma Chopova and Laura Lowena's new East London outpost comes with a permanent shop for custom kilts, entry-price merch, artist furniture, and community events.
Opener is an open-source reference implementation of the DECT NR+ massive IoT, low-latency standard
Opener is an open-source reference implementation of the DECT NR+ protocol stack, formally known as DECT-2020 NR, used for massive IoT (mMTC) and low-latency (URLLC) machine-to-machine communication applications.…
It is developed by the Opener Initiative, supported by the OpenDECT-X …
The standard itself supports up to one million devices per km², years …
It is also designed for ultra-reliable low-latency communications (URL…
35% of Subprime Consumers Remain Outside the Card Market
More than 1 in 3 subprime consumers sit outside the card market, leaving lenders and merchants with room to build a more manageable entry point to credit.…
The PYMNTS Intelligence report “Who Is the Subprime Consumer?
A Behavioral Profile,” released in May, found that subprime consumers …
They represented 17% of consumers in the United States in January, and…
Opinion: I studied Reddit forums on menopause — and found what doctors are missing
In forums on Reddit, women share tales of having perimenopause and menopause symptoms misdiagnosed or dismissed as mental health disorders, early-onset dementia, or autoimmune issues, resulting in months or years of unnecessary testing.…
They discuss sudden mood shifts of rage, and panic, and how they are r…
Severe brain fog, memory lapses, and sleeplessness from night sweats —…
Opinion: STAT+: A bill is supposed to protect U.S. biotech from Chinese competition. But there’s a loophole
Bipartisan legislation under review in Congress has the potential to significantly rejigger global drug development — and the biggest beneficiaries may not be American.…
The bill, titled the Biotech Investment National Security Act (BINSA),…
The policy is an add-on to the restrictions of the Comprehensive Outbo…
BINSA’s sponsors frame the additional policy as necessary to protect U.
Hospitals are plotting a long-shot push to roll back $1 trillion in Medicaid cuts
WASHINGTON — Hospital leaders, stung by the passage of a law that will cut nearly $1 trillion in Medicaid funding over the next decade, have been racing to remake their systems.…
And in Washington, some are building a long-shot plan to turn back the…
A personalized cancer vaccine developed by Moderna and Merck has generated widespread enthusiasm since the companies announced last week that it had succeeded in a late-stage trial.…
If regulators ultimately approve it, the treatment will be a triumph o…
But it may also be a triumph of the algorithm.
The vaccine, intismeran autogene, would be the first approved medicine…